Half-year Report

RNS Number : 6559K
Beacon Rise Holdings PLC
22 December 2022
 

 

  Company Registered number: 13620150 (English and Wales) 

 

 

 

 

 

 

 

 

 

 

 

 

BEACON RISE HOLDINGS PLC



 

 

 

 

 

 

 

 

 

 

UNAUDITED CODENSED INTERIM FINANCIAL STATEMENTS

 

FOR THE PERIOD FROM 1 APRIL 2022 TO 30 SEPTEMBER 2022



Chairman's statement

 

I am pleased to present the unaudited condensed interim financial results for the Company for the six months ended 30 September 2022.


The principal activity of the Company is to acquire businesses in the primary and secondary segments of the education technology sectors.

 

To enable the Company to pursue its principal activities, the Company initiated an Initial Public Offering ("IPO") of its securities onto the London Stock Exchange through a Standard Listing to raise the necessary funds required for the execution of the business strategy. The IPO was successfully completed and the Company's shares were admitted for trading on 25 March 2022. This listing enables the Company to raise funds for acquisitions which may be in the form of a merger, capital stock exchange, asset acquisition, stock purchase, scheme of the arrangement, reorganisation or similar business combination of an interest in an operating entity or investment.


As at the reporting period end, the Company did not have any current operations, no products were sold, and no services were performed by the Company. It did not operate or compete in any specific market, and the Company had no subsidiaries. The Company continues to seek acquisitions of UK and overseas businesses or assets with operations in the sectors that can contribute greater benefits to shareholders.

Strategy

The Company retains a flexible merge and acquisition strategy which will enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so.

The Company's strategic aim is to drive shareholder value through the acquisition of target companies in certain sectors where the Board believes there to be sustainable growth opportunities both organically, and through acquisition.

 

Financial results in the six months period ended 30 September 2022


Financial key performance indicators:

 

 

6 months

ended

30 September

2022

(Unaudited)

£

 

17 days ended

30 September

2021

(Unaudited)

£

EBITDA 

(112,822)


(48,531)

 

 

 

 

30 September

2022

(Unaudited)

 

 

 

31 March 2022

(Audited)  

 

£

 

£

Gross assets 

659,699

 

832,822

Net assets 

538,585

651,407

 



 

 

 

Gender analysis

A split of our employees and directors by gender during the period is shown below:


  Male  Female
Directors  2  1

As the Company is only in its infancy, gender of the Board is skewed towards males. This does not reflect the attitudes of the Company in any way and the Directors will promote females in the Board and in the workforce wherever possible. 

 

All the Directors are from minority ethics background.

 

Developments in the six month period ended 30 September 2022

 

In the six months period ended 30 September 2022, the Company has steadily promoted the Company's development by following aspects:

 

1.  Effective corporate governance systems implementation

The Board of Directors of the Company strictly implemented various systems in accordance with the Company Law and relevant governance and regulatory requirements of listed companies, including but not limited to strict approval system, internal control system, external announcement system, etc.

 

2.  Active review on the Company's strategy and our mission.

We have actively learnt and collected cutting-edge information on scientific and technological development, improved the global vision of board members, and created a solid reserve of professional knowledge in order to find suitable acquisition targets that are conducive to creating value for all shareholders.

 

3.  Assurance on the healthy operation of the Company.

In the past six months, the Company has been in a healthy operating condition, and has followed relevant ESG guidelines to implement a green, environmental-friendly, and efficient operating strategy to ensure that the Company's financial situation remains healthy, the Company's Board of Directors and management remain stable, and thus effectively ensuring the healthy development of the Company.

 

4.  Participation in relevant seminar and training organized by the London Stock Exchange and third-party intermediaries.

 

We have systematically studied the relevant requirements of the public announcement of listed companies and methods to promote the Company's brand value in a quality manner.

 

Risks and uncertainties

 

The Company has yet to complete an investment or acquisition, it has limited trading history. As such, the Company continued to be subject to the risks and uncertainties associated with an early-stage acquisition company.

 

The Directors are of the opinion that these risks, which were detailed in the published results for the financial period ended 31 March 2022, remain applicable to the Company.

 

Dividend

 

At this point of the Company's development, it does not anticipate declaring any dividends in the foreseeable future. Following the Company's inaugural investment or acquisition, the Directors will determine an appropriate dividend policy.

 

Looking forward, the Company will strictly enforce corporate governance and further strengthen the leadership of the Board of Directors over the Company. We have been actively looking for acquisition targets that can create long-term value for all shareholders and meanwhile we continue to be confident in our potential acquisition opportunities even if the volatility in capital markets continues to cause challenges across the markets.

 

I would like to take this opportunity to thank the shareholders for their continued support as we build Beacon Rise into a significant organisation.

 

The Interim Report and directors' responsibility statement were approved by the Board of Directors on 22 December 2022.

 

 

   

 

Xiaobing Wang

Chairman

 

22 December 2022


Directors' responsibilities statement

 

The Directors confirm, to the best of their knowledge, that these unaudited condensed interim financial statements:

 

· have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting';

· gives a true and fair view of the assets, liabilities, financial position and profit/loss of the Company;

· includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and

· includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions.

 


 

 





 

 

 

 





6 months ended 30 September 2022

17 days ended 30 September 2021




  Note

(Unaudited)

(Unaudited)





£

£

 

Administrative expenses


(112,822)

(6,298)

Costs of equity transaction


-

(42,233)

 

Loss from operations


 

(112,822)

 

(48,531)

 

Loss before taxation


 

(112,822)

 

(48,531)

Taxation on loss of ordinary activities


-

-

 

Loss for the period from continuing operations


 

(112,822)

 

(48,531)




Other comprehensive income

-

 

-

Total comprehensive loss for the period attributable to shareholders


 

(112,822)

 

(48,531)

Earnings per share (basic and dilutive)

6

(0.10)

(48,531.00)








 

 

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations. The notes on page 9 - 13 form an integral part of the condensed interim financial statements.

 

 


 





30 September 2022

(Unaudited)

31 March 2022

(Audited)

Note

£

£

 

Assets



 

Current assets




 

Other receivables


5,620

6,349

 

Cash and cash equivalents


654,079

826,473

Total current assets


 

659,699

 

832,822

 

Total assets

 

 

 

 

659,699

 

 

832,822

 

 

Liabilities



 

Current liabilities




 

Trade and other liabilities


121,114

181,415

Total current liabilities


 

121,114

 

181,415

 

Total liabilities


 

121,114

 

181,415

 

Net assets


 

538,585

 

651,407

 

 

Issued capital and reserves




 

Share capital

 7

1,122,000

1,087,000

 

Shares to be issued


-

35,000

 

Retained earnings


(583,415)

(470,593)

 

TOTAL EQUITY


538,585

651,407

 

 

 

 


Unaudited

Share capital

Shares to be issued

Retained earnings

Total

equity

 

 

£

£

£

£

At incorporation





 

Comprehensive income for the period





 

Loss for the period

-

-

(48,531)

(48,531)

 

Total comprehensive loss for the period

-

-

(48,531)

(48,531)

 

Contributions by and distributions to owners





 

Issue of share capital

1

-

-

 1

 

Transactions with owners in own capacity

  1

-

(48,531)

-

 

Balance at 30 September 2021

1

 

-

 

(48,531)

 

(48,530)

 

Unaudited

Share capital

Shares to be issued

Retained earnings

Total

equity

 

 

£

£

£

£

Balance at 1 April 2022

1,087,000

35.000

(470,593)

651,407

 

Loss for the period

-

-

(112,822)

(112,822)

 

Total comprehensive loss for the period

-

-

(112,822)

(112,822)

 

Contributions by and distributions to owners





 

Issue of share capital

35,000

(35,000)

-

-

 

Transactions with owners in own capacity

35,000

(35,000)

-

-






 

Balance at 30 September 2022

 

1,122,000

 

-

 

(583,415)

 

538,585


 

 

 

 


 

 

 

 





6 months ended 30 September

17 days ended 30 September





2022

2021





(Unaudited)

(Unaudited)





£

£

 

Cash flows from operating activities




 

Loss for the period


  (112,822) 

(48,531)

Changes in working capital:




 

Decrease in trade and other receivables


  729 

-

 

(Decrease)/increase in trade and other payables


  (60,301) 

48,531

 

Net cash used in operating activities

 


   

  (172,394) 

   

 

-

 

 

Net cash decrease in cash and cash equivalents


  (172,394) 

  -

 

Cash and cash equivalents at the beginning of period


  826,473 

-

 

Cash and cash equivalents at the end of the period


 654,079

  -

 

 


 

1.  Accounting policies

 

Going concern

 

The Company's condensed interim financial statements have been prepared on a going concern basis, which assumes that the Company will continue to meet its liabilities as they fall due.

The Directors review the Company's financial forecast against the quarterly management accounts to assess the Company's working capital requirement. The Company will carry out further fundraising when a suitable acquisition target is found.

 

It is on these considerations that the Directors have a reasonable expectation that the Company has sufficient funds and adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

 

2.

 

 

Reporting entity

 

Beacon Rise Holdings Plc (the 'Company') is a limited company incorporated in the United Kingdom. The Company's registered office is at Kemp House, 160 City Road, London, England, EC1V 2NX. The Company's principal activity is that of a parent company and the intended principal activity of the intended group is in the primary and secondary segments of the education technology sectors.

 

3.

 

 

Basis of preparation

 

These condensed interim financial statements have been prepared in accordance with International Accounting Standard ('IAS') 34 - Interim Financial Reporting. The condensed interim financial statements are for the six months to 30 September 2022, being six months from the financial year end for the Company being 31 March 2022. The interim financial statements do not include all of the information or disclosures required in the annual financial statements and should be read in conjunction with the company's audited financial statements for the period ended 31 March 2022.

The condensed interim financial statements have not been audited but the Company has engaged the Company's auditors to perform a limited scope review in accordance with the International Standard on Review Engagements 2410 issued by the Auditing Practices Board. The condensed interim financial statements do not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The figures have been prepared using applicable accounting policies and practices consistent with those adopted in the audited financial statements for the period ended 31 March 2022.

In preparing these financial statements, management has made judgments, estimates and assumptions that affect the application of the Company's accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognised prospectively.

The areas where judgments and estimates have been made in preparing the financial statements and their effects are disclosed in note 5.

The interim financial information for the period ended 30 September 2022 has not been audited or reviewed in accordance with the International Standard on Review Engagements 2410 issued by the Auditing Practices Board. The figures were prepared using applicable accounting policies and practices consistent with those adopted in the statutory accounts for the year ended 31 March 2022. The figures for the year ended 31 March 2022 have been extracted from these accounts, which have been delivered to the Registrar of Companies, and contained an unqualified audit report.

The interim financial information contained in this document does not constitute statutory accounts. In the opinion of the Directors, the financial information for this period fairly presents the financial position, result of operations and cash flows for this period.

 

3.1 Basis of measurement

The financial statements have been prepared on the historical cost basis.

 

3.2 Changes in accounting policies

  New standards, interpretations, and amendments adopted by the Company

 

During the current period the Company adopted all the new and revised standards, interpretations, and amendments that are relevant to its operations and are effective for accounting periods beginning on 1 April 2022. This adoption did not have a material effect on the accounting policies of the Company.

 

New standards, interpretations, and amendments not yet effective

 

Standards 

Impact on initial application 

Effective date

IAS 1 (Amendments) 

Classification of Liabilities as Current

1 January 2023

IAS 1 (Amendments) 

Disclosure of Accounting policies

1 January 2023

IAS 8 (Amendments) 

Definition of Accounting Estimates 

1 January 2023

IAS 12 (Amendments) 

Deferred Tax related to Assets and liabilities arising from a Single Transaction 

1 January 2023

IFRS 17 (Amendments)

Principles for the recognition, measurement, presentation and disclosure of insurance contracts

1 January 2023

The Directors are evaluating the impact that these standards may have on the financial statements of the Company. The effect of these new and amended Standards and Interpretations which are in issue but not yet mandatorily effective is not expected to be material.

 

3.3 Segmental analysis

 

The Company manages its operations in one segment, seeking a suitable investment in the primary and secondary segments of the education technology sectors. The results of this segment are regularly reviewed by the Board as a basis for the allocation of resources, in conjunction with individual investment appraisals, and to assess its performance.

 

4.

 

 

Functional and presentational currency

 

These financial statements are presented in pound sterling, which is the Company's functional currency. All amounts have been rounded to the nearest pound unless otherwise indicated.

 

 

5.

 

 

Accounting estimates and judgments

 

The Company makes estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual results may differ from these estimates and assumptions. There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial period.

 

 

 

6.

 

 

Earnings per share

 






6 months ended 30 September

17 days ended 30 September






2022

2021






(Unaudited)

(Unaudited)






£

£









Loss attributable to shareholders of Beacon Rise Holdings plc

(112,822)

(48,531)


 

Weighted number of ordinary shares in issue

1,105,361

1


Basic & dilutive earnings per share from continuing operations
(0.10)
(48,531)

 

 

 


 

 

7.

 

 

Share capital

 


Authorised

 




30 September

  30 September

31 March

31 March



2022

(Unaudited)

2022

(Unaudited)

2022

(Audited)

2022

(Audited)



Number

£

Number

£








Share Capital






Ordinary shares of £1.00 each

 

  1,122,000

 

   1,122,000

 

  1,122,000

 

   1,122,000

 



1,122,000
1,122,000
1,122,000
1,122,000

 

Issued and paid

 



30 September

30 September

31 March

31 March


2022

(Unaudited)

2022

(Unaudited)

2022

(Audited)

2022

(Audited)


Number

£

Number

£






Ordinary shares of £1.00 each

 

Issue of ordinary shares on incorporation - note (a)

1

 

 

1

1

 

 

1

Issue of ordinary shares - note (b)

49,999

49,999

49,999

49,999

Issue of ordinary shares - note (c)

1,037,000

1,037,000

1,037,000

1,037,000

Issue of ordinary shares - note (d)

35,000

35,000

-

-


 1,122,000

 1,122,000

 1,087,000

 1,087,000

 

(a)  On incorporation on 14 September 2021, the Company issued 1 ordinary share at their nominal value of £1.

(b)  On 11 November 2021, the Company issued 49,999 ordinary shares at their nominal value of £1.

(c)  On admission to the Standard List of the LSE on 25 March 2022, the Company issued 1,037,000 ordinary shares at their nominal value of £1.

(d)  On 27 June 2022, the Company issued 35,000 ordinary shares at their nominal value of £1.


 

 

8.

 

 

Related party transactions

 

During the period, £47,500 (17 days ended 30 September 2021 (unaudited): £3,479) directors' remuneration was incurred; £88,223 (17 days ended 30 September 2021 (unaudited): £3,479) deferred directors' remuneration were owing as at 30 September 2022.

 

Additionally, as at 30 September 2022, £895 (as at 31 March 2022 (audited): £41,000) was owing to the Executive Director, Mr Xiaobing Wang. The balance is unsecured and interest-free.

Other than these there were no other related party transactions.

 

 

9.

 

 

Ultimate Controlling Party

 

The ultimate controlling party is Xiaobing Wang.

 

 

10.

 

 

Capital management

 

The Company considers its capital to be equal to the sum of its total equity. The Company monitors its capital using a number of key performance indicators including working capital ratios.

The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern, in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure. The Company funds its capital requirements through the issue of new shares to investors.

 

 

11.

 

 

Events subsequent to period end

 

There were no material events subsequent to period end that require disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BDBDDBBDDGDD
UK 100

Latest directors dealings